other semaglutide medications Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Types of GLP-1 Medications for

Ultimately, every insurer and every insurance policy may vary on their terms of coverage for these medications

Rare risks include pancreatitis and gallbladder issues

The STEP 1 trial, published in the New England Journal of Medicine in 2021, showed that participants taking semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group

The other is built around body composition, appetite regulation, muscle preservation, and long-term behavioral support

Shauna Levy, especialista en medicina de la obesidad en el Centro Mdico de la Universidad de Tulane en Nueva Orleans y directora mdica del Centro Baritrico y de Prdida de Peso de Tulane